|
| Wednesday, May 20, 2020 |
|
|
经申办方推选，Novotech 荣获“CRO 领导力大奖” |
| 领先的亚太地区专业生物技术 CRO Novotech 已被《生命科学领袖》(Life Science Leader) 杂志授予享誉盛名的“CRO 领导力大奖”，该奖项是基于使用外包服务的申办者公司的调查结果得出的。 more info >> |
|
| Wednesday, April 29, 2020 |
|
|
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study |
| The Asia-Pacific's largest specialist biotech CRO Novotech has been engaged for a Phase 2 COVID-19 study by biotech sponsor Karyopharm Therapeutics Inc. more info >> |
|
| Tuesday, April 28, 2020 |
|
|
노보텍의 코로나19 임상시험 클라이언트, 아시아태평양 지역의 새로운 패스트트랙 심의과정의 혜택을 누리다 |
| 아시아·태평양 지역 최대의 바이오테크 전문 임상 시험 수탁 기관인 노보텍은 아·태 지역 내 많은 국가들이 치료제 및 백신 후보에 대한 신속 심의를 통해 클라이언트의 코로나19 임상시험을 신속하게 처리하기 위한 패스트트랙 절차를 실시하고 있다고 밝혔다. more info >> |
|
|
Novotech COVID-19 臨床試驗客戶受益於亞太地區新的快速審批流程 |
| 亞太地區最大的專業生物技術CRO Novotech表示，該地區的許多國家正在實行候選治療方法和疫苗快速審查流程，以便快速審批COVID-19 客戶的臨床試驗。 more info >> |
|
|
Novotech COVID-19 临床试验客户受益于亚太地区新的快速审批流程 |
| 亚太地区最大的专业生物技术 CRO Novotech表示，该地区的许多国家正在实行候选治疗方法和疫苗快速审查流程，以便快速审批 COVID-19 客户的临床试验。 more info >> |
|
|
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes |
| Asia-Pacific's largest specialist biotech CRO Novotech said many countries in the region were now fast-tracking their COVID-19 clients' clinical trials with expedited review processes for treatment and vaccine candidates. more info >> |
|
| Wednesday, April 8, 2020 |
|
|
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity |
| Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations. more info >> |
|
| Friday, March 20, 2020 |
|
|
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials |
| Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist for two of the prestigious Citeline Awards 2020 (formerly CARE Awards) by Informa Pharma Intelligence. more info >> |
|
| Tuesday, March 10, 2020 |
|
|
Novotech與科微範株式會社(Komipharm)簽署CRO合同，在韓國進行新型冠狀病毒肺炎臨床試驗 |
| 亞太地區最大的專業生物技術合同研究機構Novotech已被科微範株式會社選定，對作為新型冠狀病毒肺炎潛在治療方案的Panaphix進行臨床試驗。 more info >> |
|
|
Novotech与科微范株式会社(Komipharm)签署CRO合同，在韩国进行新型冠状病毒肺炎临床试验 |
| 亚太地区最大的专业生物技术合同研究机构 Novotech已被科微范株式会社选定，对作为新型冠状病毒肺炎潜在治疗方案的Panaphix进行临床试验。 more info >> |
|
|
|
|
